Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-25-015011

Head of Development sold 3,806 shares at $126.25 ($480,508)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Singhal Priya · Head of Development

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-05-19 Sale : show line 1 in the form 10b5-1 −3,806 $126.25 $480,508 5,427.14 D
Open-market sales · 3,806 sh · avg $126.25 · $480,508
Loading xslF345X05/form4.xml…